Mesenchymal stem cells for acute graft-versus-host disease

The Lancet

Volumn 372, Issue 9640, 2008, Pages 715-716

  Miura, Yuji ^a   Kami, Masahiro ^b   Tsubokura, Masaharu ^a   Takei, Naoko ^a   Komatsu, Tsunehiko ^a  

^a TEIKYO UNIVERSITY CHIBA MEDICAL CENTER   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRAFT VERSUS HOST DISEASE; DISEASE ASSOCIATION; HUMAN; LETTER; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; OVERALL SURVIVAL; PRIORITY JOURNAL; TREATMENT RESPONSE;

EID: 50149091345     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61299-4     Document Type: Letter

References (3)

1. Le Blanc K., Frassoni F., Ball L., et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371 (2008) 1579-1586
2. Fang B., Song Y., Liao L., Zhang Y., and Zhao R.C. Favorable response to human adipose tissue-derived mesenchymal stem cells in steroid-refractory acute graft-versus-host disease. Transplant Proc 39 (2007) 3358-3362
3. Le Blanc K., Rasmusson I., Sundberg B., et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363 (2004) 1439-1441